Marylebone Health
MTI Website - 1
Leading health and human performance clinic Marylebone Health has announced the introduction of new, more accessible VO2 max testing technology from Danish MedTech startup VentriJect.
The group will be using VentriJect’s Seismofit device, which estimates VO2 max in under three minutes without the need for exercise, in both its Harley Street clinic and newly opened Chelsea Barracks site. The device estimates Cardiorespiratory Fitness (CRF) using a technique called seismocardiography, which uses a small sensor to register the movements in the chest, caused by the beating heart, and an advanced proprietary algorithm. This provides a clinically validated way to estimate VO2 max, which is an indicator of CRF.
VO2 max is the measure of the maximum amount of oxygen a person can use during exercise, expressed in millilitres of oxygen consumed per minute per kilogram of body weight. This has made it an increasingly popular measurement for fitness enthusiasts at all levels, as it’s an excellent indicator of general wellbeing, mortality and performance.
It is usually measured through a Cardiopulmonary Exercise Test (CPET) test, the most accurate form of VO2 max testing. However, this technique is not accessible for most people as it takes over 20 minutes to conduct and requires intense exercise, so is unsuitable for children, the elderly and those with an injury or disability. VentriJect’s device eliminates these barriers and makes an accurate, cost effective, estimation of VO2 max accessible for all.
Seismofit is an excellent addition to Marylebone’s roster, as the group specialises in health and sports performance services. This includes VO2 max testing, strength diagnostics, and diverse services, catering to clients from pre/post-operative patients to elite athletes, optimising their physical capabilities.
Their expert team of over 40 clinicians boasts a vast range of clinical expertise across the NHS, private practice, high performance sport and more. Using new technology like Seismofit will allow them to offer an alternative VO2 max testing service for those unwilling or unable to undertake the usual, arduous test, in a way which integrates seamlessly into existing fitness methodologies.
Mikkel Kristiansen, CEO of VentriJect said: “I’m delighted to be working with Marylebone Health as they roll out Seismofit in their clinic. The group are at the forefront of innovation in health technology and always want to offer specialist but accessible and cost-effective services to their clients, we’re excited that Seismofit is now being used to help their clients better understand their health. The device is fast becoming a must-have for premium health providers, gyms and health clubs, and we can’t wait to see its continued growth in this area.”
Liz Moore, Managing Director of Marylebone Health Group added: “Across all our sites, we’re always looking for new and exciting ways for our users to understand & ultimately improve their health. VentriJect’s Seismofit fits this bill perfectly. Assessing VO2 max has always been a vital part of what we do; Having offered the gold standard CPET for over 10 years, it’s important for us to make this process easier and more accessible to all. This will level up our capabilities and ensure that clients are always getting the best, cutting-edge service without barriers.”
Both traditional CPET and new Seismofit VO2 max estimations are available at Marylebone Health’s Harley Street clinic.
